Trial Profile
A Phase 1 Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Nov 2018
At a glance
- Drugs TG 02 S*Bio/Adastra Pharmaceuticals (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Sponsors Lee Pharmaceuticals
- 18 Nov 2018 New trial record